Risk of microvascular complications of T1DM

被引：0

|

作者：

Claire Greenhill

机构：

来源：

Nature Reviews Endocrinology | 2016年 / 12卷 / 3期

关键词：

D O I：

10.1038/nrendo.2016.3

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：124 / 124

相关论文

共 50 条

[31] Is the Dawn Phenomenon Predictable in T1DM?
Bouchonville, Matthew
Duran-Valdez, Elizabeth
Schade, David S.
DIABETES, 2013, 62 : A44 - A45
[32] THERAPY Immunotherapy advance for T1DM
Greenhill, Claire
NATURE REVIEWS ENDOCRINOLOGY, 2017, 13 (10) : 564 - 564
[33] Immunotherapy for T1DM—still not there yet
Raffaella Buzzetti
Nature Reviews Endocrinology, 2013, 9 : 697 - 698
[34] The largest study of genetics of T1DM
Starling S.
Nature Reviews Endocrinology, 2021, 17 (9) : 515 - 515
[35] Innate cell crosstalk in T1DM
Carol Wilson
Nature Reviews Endocrinology, 2013, 9 (3) : 127 - 127
[36] T1DM incidence trends in Europe
Carol Wilson
Nature Reviews Endocrinology, 2012, 8 (8) : 446 - 446
[37] Prolactin As an Adjunct in Treatment of T1DM
Hyslop, Colin
Tsai, Sue
Santamaria, Pere
Huang, Carol
ENDOCRINE REVIEWS, 2014, 35 (03)
[38] Progression of atherosclerosis in adolescents with T1DM
Krantz, JS
Kaufman, FR
Liu, CR
Mack, W
Hodis, H
DIABETES, 2002, 51 : A170 - A170
[39] The genetic architecture of DKD in T1DM
Ellen F. Carney
Nature Reviews Nephrology, 2016, 12 (12) : 714 - 714
[40] Is mortalin a candidate gene for T1DM?
Johannesen, J
Pie, A
Karlsen, AE
Larsen, ZM
Jensen, A
Vissing, H
Kristiansen, OP
Pociot, F
Nerup, J
AUTOIMMUNITY, 2004, 37 (6-7) : 423 - 430

← 1 2 3 4 5 →